title: Elafin: a possible new biomarker and immunohistochemical stain for pre-engraftment syndrome.
authors.forename: Anna H
authors.initials: AH
authors.lastname: Chacon
authors.forename: Uzma
authors.initials: U
authors.lastname: Farooq
authors.forename: Michael I
authors.initials: MI
authors.lastname: Shiman
authors.forename: George W
authors.initials: GW
authors.lastname: Elgart
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D001707:Biopsy, Needle; D016543:Central Nervous System Neoplasms / Q000473:pathology / Q000601:surgery; D053492:Elafin / Q000097:blood* / Q000235:genetics; D004890:Erythema / Q000097:blood* / Q000209:etiology; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000097:blood*; D006086:Graft vs Host Disease / Q000097:blood* / Q000175:diagnosis; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D007150:Immunohistochemistry; D008223:Lymphoma / Q000473:pathology / Q000601:surgery; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D053492:Elafin; C506806:PI3 protein, human